Filing Details

Accession Number:
0001104659-17-012149
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-27 21:11:56
Reporting Period:
2017-02-23
Filing Date:
2017-02-27
Accepted Time:
2017-02-27 21:11:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651308 Beigene Ltd. BGNE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662982 Xiaodong Wang C/O Mourant Ozannes Corporate Services
94 Solaris Avenue
Camana Bay E9 KY1-1108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2017-02-23 5,505 $38.57 194,495 No 4 S Direct
American Depositary Shares Disposition 2017-02-24 27,902 $38.13 166,593 No 4 S Direct
American Depositary Shares Disposition 2017-02-24 500 $38.54 166,093 No 4 S Direct
American Depositary Shares Disposition 2017-02-27 4,444 $38.10 161,649 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 12,525,393 Direct
Ordinary Shares 214,531 Indirect See Footnote
Footnotes
  1. Each American Depositary Share represents 13 Ordinary Shares.
  2. The sale was effected pursuant to a Rule 105b-1 trading plan adopted by the Reporting Person.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.48 to $38.4784, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price within the ranges set forth in footnotes (3) to (5).
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.48 to $38.59, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.81 to $38.49, inclusive.
  6. These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.